Castle Biosciences (CSTL) Other Working Capital Changes (2018 - 2026)

Castle Biosciences (CSTL) has 9 years of Other Working Capital Changes data on file, last reported at $530000.0 in Q1 2026.

• Quarterly Other Working Capital Changes fell 84.24% year-over-year to $530000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 million (down 185.93% YoY) and the FY2025 annual result came in at $366000.0, up 239.69% from the prior year.
• Other Working Capital Changes grew to $530000.0 in Q1 2026 per CSTL's latest filing, from -$4.2 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $5.4 million in Q3 2025, with the low at -$4.2 million in Q2 2025.
• Average Other Working Capital Changes over 5 years is $51647.1, with a median of $148000.0 recorded in 2023.
• Year-over-year, Other Working Capital Changes slumped 4752.5% in 2024 and jumped 1362.61% in 2025.
• Castle Biosciences' Other Working Capital Changes stood at -$2.5 million in 2022, then surged by 98.39% to -$40000.0 in 2023, then tumbled by 4752.5% to -$1.9 million in 2024, then tumbled by 114.79% to -$4.2 million in 2025, then jumped by 112.71% to $530000.0 in 2026.
• Business Quant data shows CSTL's Other Working Capital Changes at $530000.0 in Q1 2026, -$4.2 million in Q4 2025, and $5.4 million in Q3 2025.